All results
1 results for randomized controlled open label single ascending dose phase iii study investigate
-
BOSTON 3
The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and…
- Ages
- 18 Years - N/A
- Sexes
- All